Fujian Haixi Pharmaceuticals Co., Ltd. (HKG:2637)
Hong Kong · Delayed Price · Currency is HKD 227.20
+7.40 (3.37%)
Last updated: May 19, 2026, 11:57 AM HKT
HKG:2637 Market Cap
HKG:2637 has a market cap or net worth of 17.3 billion as of May 18, 2026.
Market Cap
17.30B
Enterprise Value
15.94B
Revenue
648.05M
Ranking
n/a
PE Ratio
77.55
Stock Price
227.20
Market Cap Chart
Since October 20, 2025, HKG:2637's market cap has increased from 8.20B to 17.30B, an increase of 110.94%. That is a compound annual growth rate of 265.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 18, 2026 | 17.30B | 61.62% |
| Dec 31, 2025 | 10.70B | 30.52% |
| Oct 20, 2025 | 8.20B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| China Resources Pharmaceutical Group | 30.97B |
| Simcere Pharmaceutical Group | 29.37B |
| China Medical System Holdings | 27.71B |
| Sunshine Lake Pharma | 22.99B |
| Grand Pharmaceutical Group | 20.73B |
| The United Laboratories International Holdings | 18.37B |
| Consun Pharmaceutical Group | 12.61B |
| CanSino Biologics | 11.64B |